The Latest Cardiac and Vascular News
CLICHY, France–(BUSINESS WIRE)–The medtech company CorWave is taking a new step in its development. Already located in Clichy, next to Paris, the industrial start-up is preparing to move to larger premises capable of hosting its R&D center and the manufacturing facility needed to enter the clinical and commercial phases. The […]
Que Dallara joins as EVP & President, Diabetes Mike Marinaro named President, Surgical Robotics Dr. Kweli Thompson named President, Cardiac Rhythm Management DUBLIN, March 17, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced leadership transitions for three of its Operating Units – Diabetes, Surgical Robotics, and Cardiac Rhythm Management – […]
CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) today announced the publication of an article entitled “BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Study” in the prestigious American Journal of Respiratory and Critical Care Medicine – which has an impact factor of 21.4. The article […]
PLANO, Texas, March 17, 2022 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, announced today that Bill R. Sanford will be retiring as Chair of the Integer Board of Directors at the conclusion of the Company’s 2022 annual meeting of stockholders, which is scheduled […]
– Received tentative FDA approval of YUTREPIA™ (treprostinil) inhalation powder – Expanded use of Treprostinil Injection to include subcutaneous administration – Preparing to launch YUTREPIA in late-2022 pending final FDA approval – Company to host webcast and conference call today at 8:30 a.m. ET MORRISVILLE, N.C., March 17, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation […]
BOSTON, March 17, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases, today announced that the Company will be added to the Russell 2000® and Russell 3000® Indexes, effective on Friday, […]
Prospective multicenter study evaluated the safety and efficacy of a PEG-based liquid embolic in treating hypervascular tumors BEDFORD, Mass., March 15, 2022 /PRNewswire/ — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the publication of resultsi from the first-in-human clinical trial of Embrace™ Hydrogel Embolic System (HES) […]
Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China via an official importation agent, has placed an order of ten (10) Mentice VIST simulator packages including the Siemens Virtual Patient Link software to be bundled with the Corindus CorPath GRX Robitic system sales […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the first in-human experience with Propel™, its first-generation percutaneous ventricular assist device (pVAD), offering hemodynamic support for patients undergoing high-risk […]
Physicians accessing GE Healthcare’s MUSE, a cardiac management system that connects to and integrates into the electronic medical record (EMR), can now view and interpret in MUSE ECGs taken by patients using AliveCor’s KardiaMobile 6L personal ECG device, strengthening the care continuum from hospital into the home, or anytime, anywhere. Used […]
